Vertex Pharmaceuticals Raises Annual Revenue Forecast Due to Cystic Fibrosis Drug Strength

Vertex Pharmaceuticals has increased its annual revenue forecast, attributing the positive outlook to the strong performance of its cystic fibrosis drugs.